mosedipimod
enzychem lifescience
['thanks', 'ec-18']
#asco22 thanks for the good times. chicago in the spring is awesome. check out our poster online #351 in symptoms and survivorship. a potential novel agent, ec-18, for mucositis mitigation. keep your peeled for phase iii 
Radiation Oncologist | OU Program Director| NRG Head & Neck committee | breast cancer | ASTRO state captain| Family, food, running, and yoga | ????